Kim L - Search Results

1

Transapical transcatheter aortic valve replacement in patients with or without prior coronary artery bypass graft operation.

Voudris KV, Wong SC, Kaple R, Kampaktsis PN, de Biasi AR, Weiss JS, Devereux R, Krieger K, Kim L, Swaminathan RV, Feldman DN, Singh H, Skubas NJ, Minutello RM, Bergman G, Salemi A. Voudris KV, et al. Among authors: kim l. J Cardiothorac Surg. 2016 Nov 29;11(1):158. doi: 10.1186/s13019-016-0551-7. J Cardiothorac Surg. 2016. PMID: 27899140 Free PMC article.

2

Chemotherapy-induced takotsubo cardiomyopathy.

Kim L, Karas M, Wong SC. Kim L, et al. J Invasive Cardiol. 2008 Dec;20(12):E338-40. J Invasive Cardiol. 2008. PMID: 19057042

3

Efficacy and safety of bivalirudin in patients with diabetes mellitus undergoing percutaneous coronary intervention in current clinical practice.

Kim LK, Wong SC, Minutello RM, Bergman G, Feldman DN. Kim LK, et al. J Invasive Cardiol. 2010 Mar;22(3):94-100. J Invasive Cardiol. 2010. PMID: 20197573

4

Door-to-balloon time in primary percutaneous coronary intervention predicts degree of myocardial necrosis as measured using cardiac biomarkers.

Minutello RM, Kim L, Aggarwal S, Cuomo LJ, Feldman DN, Wong SC. Minutello RM, et al. Among authors: kim l. Tex Heart Inst J. 2010;37(2):161-5. Tex Heart Inst J. 2010. PMID: 20401287 Free PMC article.

5

Impact of genetic insights into mendelian disease on cardiovascular clinical practice.

Kim L, Devereux RB, Basson CT. Kim L, et al. Circulation. 2011 Feb 8;123(5):544-50. doi: 10.1161/CIRCULATIONAHA.109.914804. Circulation. 2011. PMID: 21300962 Review. No abstract available.

6

Prognostic value of cardiac troponin-I or troponin-T elevation following nonemergent percutaneous coronary intervention: a meta-analysis.

Feldman DN, Kim L, Rene AG, Minutello RM, Bergman G, Wong SC. Feldman DN, et al. Among authors: kim l. Catheter Cardiovasc Interv. 2011 Jun 1;77(7):1020-30. doi: 10.1002/ccd.22962. Epub 2011 May 13. Catheter Cardiovasc Interv. 2011. PMID: 21574239

7

Novel antiplatelet therapies.

Kim L, Charitakis K, Swaminathan RV, Feldman DN. Kim L, et al. Curr Atheroscler Rep. 2012 Feb;14(1):78-84. doi: 10.1007/s11883-011-0216-x. Curr Atheroscler Rep. 2012. PMID: 22102061 Review.

8

Impact of long-term statin therapy on postprocedural myocardial infarction in patients undergoing nonemergency percutaneous coronary intervention.

Gordin J, Haider A, Swaminathan RV, Kim LK, Minutello RM, Bergman G, Wong SC, Feldman DN. Gordin J, et al. Am J Cardiol. 2012 Nov 15;110(10):1397-404. doi: 10.1016/j.amjcard.2012.06.052. Epub 2012 Aug 2. Am J Cardiol. 2012. PMID: 22858186

9

Reperfusion therapy in ST-elevation myocardial infarction: guidelines, strategies, pharmacology, and stent selection.

Ghosh BD, Swaminathan RV, Kim LK, Feldman DN. Ghosh BD, et al. Among authors: kim lk. Minerva Med. 2012 Dec;103(6):431-9. Minerva Med. 2012. PMID: 23229365 Review.

10

Impact of peripheral vascular disease on short- and long-term outcomes in patients undergoing non-emergent percutaneous coronary intervention in the drug-eluting stent era.

Midwall S, Swaminathan RV, Charitakis K, Kim LK, Gordin J, Hriljac I, Minutello RM, Bergman G, Wong SC, Feldman DN. Midwall S, et al. J Invasive Cardiol. 2013 Mar;25(3):132-6. J Invasive Cardiol. 2013. PMID: 23468442 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,755 results

Search Page

Filters